Iron and cancer risk-a systematic review and meta-analysis of the epidemiological evidence

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 1, 2014, Pages 12-31

  Fonseca Nunes, Ana ^a   Jakszyn, Paula ^a   Agudo, Antonio ^a  

^a CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; HEME;

BLADDER CANCER; BREAST CANCER; CANCER RISK; CARCINOGENICITY; COLON CANCER; COLORECTAL CANCER; DISEASE MARKER; DNA DAMAGE; ESOPHAGUS CANCER; FERRITIN BLOOD LEVEL; HEMOCHROMATOSIS; HUMAN; IRON INTAKE; IRON OVERLOAD; IRON STORAGE; LUNG CANCER; META ANALYSIS (TOPIC); MOUTH CANCER; NUTRITIONAL ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; STOMACH CANCER; SYSTEMATIC REVIEW;

EPIDEMIOLOGIC STUDIES; HUMANS; IRON, DIETARY; NEOPLASMS; RISK FACTORS;

EID: 84892708503     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0733     Document Type: Review

References (122)

1. Huang X. Iron overload and its association with cancer risk in humans: evidence for iron as a carcinogenic metal. Mutat Res 2003;533:153-71.
2. Toyokuni S. Role of iron in carcinogenesis: cancer as a ferrotoxic disease. Cancer Sci 2009;100:9-16.
3. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol 2007;69:69-85.
4. McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO Vitamin and Mineral Nutrition Information System, 1993-2005. Public Health Nutr 2009;12: 444-54.
5. Torti SV, Torti FM. Iron and cancer: more ore to be mined. Nat Rev Cancer 2013;13:342-55.
6. Worwood M. Inherited iron loading: genetic testing in diagnosis and management. Blood Rev 2005;19:69-88.
7. Toth I, Yuan L, Rogers JT, Boyce H, Bridges KR. Hypoxia alters ironregulatory protein-1 binding capacity and modulates cellular iron homeostasis in human hepatoma and erythroleukemia cells. J Biol Chem 1999;274:4467-73.
8. Hambidge M. Biomarkers of trace mineral intake and status. J Nutr 2003;133 Suppl 3:948S-55.
9. Richmond HG. Induction of sarcoma in the rat by iron-dextran complex. Br Med J 1959;1:947-9.
10. Greenberg G. Sarcoma after intramuscular iron injection. Br Med J 1976;1:1508-9.
11. Bonnett R, Holleyhead R, Johnson BL, Randall EW. Reaction of acidified nitrite solutions with peptide derivatives: evidence for nitrosamine and thionitrite formation from 15N N.m.r. studies. J Chem Soc Perkin 1 1975;2261-41.
12. Cross AJ, Pollock JR, Bingham SA. Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat. Cancer Res 2003;63:2358-60.
13. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington DC: AICR; 2007.
14. Lee PL, Beutler E. Regulation of hepcidin and iron-overload disease. Annu Rev Pathol 2009;4:489-515.
15. Kowdley KV. Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 2004;127:S79-86.
16. Nelson RL. Iron and colorectal cancer risk: human studies. Nutr Rev 2001;59:140-8.
17. Agudo A, Bonet C, Sala N, Munoz X, Aranda N, Fonseca-Nunes A, et al. Hemochromatosis (HFE) gene mutations and risk of gastric cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Carcinogenesis 2013;34:1244-50.
18. Bastide NM, Pierre FH, Corpet DE. Heme iron from meat and risk of colorectal cancer: a meta-analysis and a review of the mechanisms involved. Cancer Prev Res (Phila) 2011;4:177-84.
19. Qiao L, Feng Y. Intakes of heme iron and zinc and colorectal cancer incidence: a meta-analysis of prospective studies. Cancer Causes Control 2013;24:1175-83.
20. Lee DH, Anderson KE, Folsom AR, Jacobs DRJr. Heme iron, zinc and upper digestive tract cancer: the Iowa Women's Health Study. Int J Cancer 2005;117:643-7.
21. Cross AJ, Harnly JM, Ferrucci LM, Risch A, Mayne ST, Sinha R. Developing a heme iron database for meats according to meat type, cooking method and doneness level. Food Nutr Sci 2012; 3:905-13.
22. Szoke D, Panteghini M. Diagnostic value of transferrin. Clin Chim Acta 2012;413:1184-9.
23. MacKenzie EL, Iwasaki K, Tsuji Y. Intracellular iron transport and storage: from molecular mechanisms to health implications. Antioxid Redox Signal 2008;10:997-1030.
24. Cook J. The nutritional assessment of iron status. Arch Latinoam Nutr 1999;49:11S-4.
25. Kato I, Dnistrian AM, Schwartz M, Toniolo P, Koenig K, Shore RE, et al. Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int J Cancer 1999;80:693-8.
26. O'Doherty MG, Abnet CC, Murray LJ, Woodside JV, Anderson LA, Brockman JD, et al. Iron intake and markers of iron status and risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Causes Control 2010;21:2269-79.
27. WHO/UNICEF/UNU. Iron Deficiency anaemia: assessment, prevention and control.WHO/NHD/01.3. Geneva, Switzerland: World Health Organization; 2001.
28. Hartemink N, Boshuizen HC, Nagelkerke NJ, Jacobs MA, van Houwelingen HC. Combining risk estimates from observational studies with different exposure cutpoints: a meta-analysis on body mass index and diabetes type 2. Am J Epidemiol 2006;163:1042-52.
29. Deeks JJ, Altman DG, Bradburn MJ. Statistical methods for examining heterogeneity and combining results from several studies in meta-analysis. In: Egger M, Smith GD, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. London, England: BMJ Publishing Group; 2008. p. 285-312.
30. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med 2002;21:1539-58.
31. Deneo-Pellegrini H, De Stefani E, Boffetta P, Ronco A, Mendilaharsu M. Dietary iron and cancer of the rectum: a case-control study in Uruguay. Eur J Cancer Prev 1999;8:501-8.
32. Kallianpur AR, Lee SA, Xu WH, Zheng W, Gao YT, Cai H, et al. Dietary iron intake and risk of endometrial cancer: a populationbased case-control study in Shanghai, China. Nutr Cancer 2010; 62:40-50.
33. Senesse P, Meance S, Cottet V, Faivre J, Boutron-Ruault MC. High dietary iron and copper and risk of colorectal cancer: a case-control study in Burgundy, France. Nutr Cancer 2004;49:66-71.
34. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-917.
35. Cross AJ, Ferrucci LM, Risch A, Graubard BI, Ward MH, Park Y, et al. Alarge prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. Cancer Res 2010;70:2406-14.
36. Zhang X, Giovannucci EL, Smith-Warner SA, Wu K, Fuchs CS, Pollak M, et al. A prospective study of intakes of zinc and heme iron and colorectal cancer risk in men and women. Cancer Causes Control 2011;22:1627-37.
37. Balder HF, Vogel J, Jansen MC, Weijenberg MP, Van den Brandt PA, Westenbrink S, et al. Heme and chlorophyll intake and risk of colorectal cancer in the Netherlands cohort study. Cancer Epidemiol Biomarkers Prev 2006;15:717-25.
38. Hara A, Sasazuki S, Inoue M, Iwasaki M, Shimazu T, Sawada N, et al. Zinc and heme iron intakes and risk of colorectal cancer: a population-based prospective cohort study in Japan. Am J Clin Nutr 2012;96:864-73.
39. Lee DH, Anderson KE, Harnack LJ, Folsom AR, Jacobs DR Jr. Heme iron, zinc, alcohol consumption, and colon cancer: Iowa Women's Health Study. J Natl Cancer Inst 2004;96:403-7.
40. Kabat GC, Miller AB, Jain M, Rohan TE. A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women. Br J Cancer 2007;97:118-22.
41. Larsson SC, Adami HO, Giovannucci E, Wolk A. Re: Heme iron, zinc, alcohol consumption, and risk of colon cancer. J Natl Cancer Inst 2005;97:232-3.
42. Ekblom K, Marklund SL, Palmqvist R, Van Guelpen B, Hallmans G, Weinehall L, et al. Iron biomarkers in plasma, HFE genotypes, and the risk for colorectal cancer in a prospective setting. Dis Colon Rectum 2012;55:337-44.
43. Cross AJ, Gunter MJ, WoodRJ, Pietinen P, Taylor PR, Virtamo J, et al. Iron and colorectal cancer risk in the alpha-tocopherol, beta-carotene cancer prevention study. Int J Cancer 2006;118:3147-52.
44. Wurzelmann JI, Silver A, Schreinemachers DM, Sandler RS, Everson RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1996;5:503-7.
45. Levi F, Pasche C, Lucchini F, la Vecchia C. Selected micronutrients and colorectal cancer. A case-control study from the canton of Vaud, Switzerland. Eur J Cancer 2000;36:2115-9.
46. Sun Z, Zhu Y, Wang PP, Roebothan B, Zhao J, Zhao J, et al. Reported intake of selected micronutrients and risk of colorectal cancer: results from a large population-based case-control study in Newfoundland, Labrador and Ontario, Canada. Anticancer Res 2012;32:687-96.
47. Sesink AL, Termont DS, Kleibeuker JH, van der MR. Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res 1999;59:5704-9.
48. Bingham SA, Pignatelli B, Pollock JR, Ellul A, Malaveille C, Gross G, et al. Does increased endogenous formation of N-nitrosocompounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 1996;17:515-23.
49. BinghamSA, Hughes R, Cross AJ. Effect of white versus red meat on endogenous N-nitrosation in the human colon and further evidence of a dose response. J Nutr 2002;132:3522S-5.
50. Kabat GC, Cross AJ, Park Y, Schatzkin A, Hollenbeck AR, Rohan TE, et al. Intakes of dietary iron and heme-iron and risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr 2010;92:1478-83.
51. Kabat GC, Miller AB, Jain M, Rohan TE. Dietary iron and heme iron intake and risk of breast cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 2007;16:1306-8.
52. Ferrucci LM, Cross AJ, Graubard BI, Brinton LA, McCarty CA, Ziegler RG, et al. Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Br J Cancer 2009;101:178-84.
53. Kallianpur AR, Lee SA, Gao YT, Lu W, Zheng Y, Ruan ZX, et al. Dietary animal-derived iron and fat intake and breast cancer risk in the Shanghai Breast Cancer Study. Breast Cancer Res Treat 2008; 107:123-32.
54. Adzersen KH, Jess P, Freivogel KW, Gerhard I, Bastert G. Raw and cooked vegetables, fruits, selected micronutrients, and breast cancer risk: a case-control study in Germany. Nutr Cancer 2003; 46:131-7.
55. Levi F, Pasche C, Lucchini F, La VC. Dietary intake of selected micronutrients and breast-cancer risk. Int J Cancer 2001;91:260-3.
56. Cade J, Thomas E, Vail A. Case-control study of breast cancer in south east England: nutritional factors. J Epidemiol Community Health 1998;52:105-10.
57. Kallianpur AR, Hall LD, Yadav M, Christman BW, Dittus RS, Haines JL, et al. Increased prevalence of the HFE C282Y hemochromatosis allele in women with breast cancer. Cancer Epidemiol Biomarkers Prev 2004;13:205-12.
58. Cross AJ, Freedman ND, Ren J, Ward MH, Hollenbeck AR, Schatzkin A, et al. Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am J Gastroenterol 2011;106:432-42.
59. Jakszyn P, Agudo A, Lujan-Barroso L, Bueno-de-Mesquita HB, Jenab M, Navarro C, et al. Dietary intake of heme iron and risk of gastric cancer in the European prospective investigation into cancer and nutrition study. Int J Cancer 2012;130:2654-63.
60. Cook MB, Kamangar F, Weinstein SJ, Albanes D, Virtamo J, Taylor PR, et al. Iron in relation to gastric cancer in the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Cancer Epidemiol Biomarkers Prev 2012;21:2033-42.
61. Pelucchi C, Tramacere I, Bertuccio P, Tavani A, Negri E, La VC. Dietary intake of selected micronutrients and gastric cancer risk: an Italian case-control study. Ann Oncol 2009;20:160-5.
62. Cornee J, Pobel D, Riboli E, Guyader M, Hemon B. A case-control study of gastric cancer and nutritional factors in Marseille, France. Eur J Epidemiol 1995;11:55-65.
63. Ward MH, Cross AJ, Abnet CC, Sinha R, Markin RS, Weisenburger DD. Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach. Eur J Cancer Prev 2012;21:134-8.
64. Nomura A, Chyou PH, Stemmermann GN. Association of serum ferritin levels with the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 1992;1:547-50.
65. Gonzalez CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:345-54.
66. Jakszyn P, Bingham S, Pera G, Agudo A, Luben R, Welch A, et al. Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 2006;27:1497-501.
67. Pra D, Rech Franke SI, Pegas Henriques JA, Fenech M. Apossible link between iron deficiency and gastrointestinal carcinogenesis. Nutr Cancer 2009;61:415-26.
68. Steffen A, Bergmann MM, Sanchez MJ, Chirlaque MD, Jakszyn P, Amiano P, et al. Meat and heme iron intake and risk of squamous cell carcinoma of the upper aero-digestive tract in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2012;21:2138-48.
69. Tasevska N, Sinha R, Kipnis V, Subar AF, Leitzmann MF, Hollenbeck AR, et al. A prospective study of meat, cooking methods, meat mutagens, heme iron, and lung cancer risks. Am J Clin Nutr 2009;89:1884-94.
70. Tasevska N, Cross AJ, Dodd KW, Ziegler RG, Caporaso NE, Sinha R. No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial. Int J Cancer 2011;128:402-11.
71. Lee DH, Jacobs DR Jr. Interaction among heme iron, zinc, and supplemental vitamin C intake on the risk of lung cancer: Iowa Women's Health Study. Nutr Cancer 2005;52:130-7.
72. Zhou W, Park S, Liu G, Miller DP, Wang LI, Pothier L, et al. Dietary iron, zinc, and calcium and the risk of lung cancer. Epidemiology 2005;16:772-9.
73. Gutteridge JM, Mumby S, Quinlan GJ, Chung KF, Evans TW. Prooxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun 1996;220:1024-7.
74. Cross AJ, Sinha R. Meat-related mutagens/carcinogens in the etiology of colorectal cancer. Environ Mol Mutagen 2004;44:44-55.
75. International Agency for Research on Cancer. Monographs on the evaluation on the carcinogenic risk of chemicals to humans. Polynuclear aromatic compounds. Lyon, France: IARC; 1985.
76. Ohgaki H, Takayama S, Sugimura T. Carcinogenicities of heterocyclic amines in cooked food. Mutat Res 1991;259:399-410.
77. Kazerouni N, Sinha R, Hsu CH, Greenberg A, Rothman N. Analysis of 200 food items for benzo[a]pyrene and estimation of its intake in an epidemiologic study. Food Chem Toxicol 2001;39:423-36.
78. Reinik M, Tamme T, Roasto M, Juhkam K, Tenno T, Kiis A. Polycyclic aromatic hydrocarbons (PAHs) in meat products and estimated PAH intake by children and the general population in Estonia. Food Addit Contam 2007;24:429-37.
79. Buettner GR, Jurkiewicz BA. Catalytic metals, ascorbate and free radicals: combinations to avoid. Radiat Res 1996;145:532-41.
80. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 1998;392:559.
81. Genkinger JM, Friberg E, Goldbohm RA, Wolk A. Long-term dietary heme iron and red meat intake in relation to endometrial cancer risk. Am J Clin Nutr 2012;96:848-54.
82. Kabat GC, Miller AB, Jain M, Rohan TE. Dietary iron and haem iron intake and risk of endometrial cancer: a prospective cohort study. Br J Cancer 2008;98:194-8.
83. Jakszyn P, Gonzalez CA, Lujan-Barroso L, Ros MM, Bueno-de-Mesquita HB, Roswall N, et al. Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2011;20:555-9.
84. Molina-Montes E, Wark PA, Sanchez MJ, Norat T, Jakszyn P, Lujan-Barroso L, et al. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int J Cancer 2012;131:E1134-47.
85. Jakszyn PG, Allen NE, Lujan-Barroso L, Gonzalez CA, Key TJ, Fonseca-Nunes A, et al. Nitrosamines and heme iron and risk of prostate cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2012;21: 547-51.
86. Richie JP Jr, Kleinman W, Marina P, Abraham P, Wynder EL, Muscat JE. Blood iron, glutathione, and micronutrient levels and the risk of oral cancer. Nutr Cancer 2008;60:474-82.
87. Palmer S. Diet, nutrition, and cancer. Prog Food Nutr Sci 1985;9: 283-341.
88. Graf E, Eaton JW. Dietary suppression of colonic cancer. Fiber or phytate? Cancer 1985;56:717-8.
89. Hann HW, Stahlhut MW, Blumberg BS. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res 1988;48:4168-70.
90. Nelson RL. Dietary iron and colorectal cancer risk. Free Radic Biol Med 1992;12:161-8.
91. Babbs CF. Free radicals and the etiology of colon cancer. Free Radic Biol Med 1990;8:191-200.
92. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Oral ferrous sulfate supplements increase the free radical-generating capacity of feces from healthy volunteers. Am J Clin Nutr 1999;69:250-5.
93. Porres JM, Stahl CH, Cheng WH, Fu Y, Roneker KR, Pond WG, et al. Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high dietary iron intake. Proc Soc Exp Biol Med 1999;221:80-6.
94. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Increases in the concentrations of available iron in response to dietary iron supplementation are associatedwith changes in crypt cell proliferation in rat large intestine. J Nutr 1998;128:175-9.
95. Hann HW, Stahlhut MW, Menduke H. Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice. Cancer 1991;68:2407-10.
96. Beckman LE, Van Landeghem GF, Sikstrom C, Wahlin A, Markevarn B, Hallmans G, et al. Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. Carcinogenesis 1999;20:1231-3.
97. Nicolas G, Bennoun M, Devaux I, Beaumont C, Grandchamp B, Kahn A, et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice. Proc Natl Acad Sci U S A 2001;98:8780-5.
98. Fracanzani AL, Conte D, Fraquelli M, Taiolo E, Mattioli M, Losco A, et al. Increased cancer risk in a cohort of 230 patients with hereditary hemachromatosis in comparison to matched control patientes with non-iron-related chronic liver disease. Hepatology 2001;33:647-51.
99. Hsing AW, McLaughlin JK, Olsen JH, Mellemkjar L, Wacholder S, Fraumeni JF Jr. Cancer risk following primary hemochromatosis: a population-based cohort study in Denmark. Int J Cancer 1995;60: 160-2.
100. Elmberg M, Hultcrantz R, Ekbom A, Brandt L, Olsson S, Olsson R, et al. Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives. Gastroenterology 2003;125: 1733-41.
101. Geier D, Hebert B, Potti A. Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis. Anticancer Res 2002;22: 3797-9.
102. Grant WB. An ecological study of cancer mortality rates including indices for dietary iron and zinc. Anticancer Res 2008;28: 1955-63.
103. Crombie IK. The limitations of case-control studies in the detection of environmental carcinogens. J Epidemiol Community Health 1981;35: 281-7.
104. Schaefer EJ, Augustin JL, Schaefer MM, Rasmussen H, Ordovas JM, Dallal GE, et al. Lack of efficacy of a food-frequency questionnaire in assessing dietary macronutrient intakes in subjects consuming diets of known composition. Am J Clin Nutr 2000;71: 746-51.
105. Monsen ER, Balintfy JL. Calculating dietary iron bioavailability: refinement and computerization. J Am Diet Assoc 1982;80:307-11.
106. Cook JD, Skikne BS, Lynch SR, Reusser ME. Estimates of iron sufficiency in the US population. Blood 1986;68:726-31.
107. Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 1994;56:364-9.
108. Stevens RG, Jones DY, Micozzi MS, Taylor PR. Body iron stores and the risk of cancer. N Engl J Med 1988;319:1047-52.
109. Knekt P, Reunanen A, Takkunen H, Aromaa A, Heliövaara M, Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 1994;56:379-82.
110. Beutler E, Felitti V, Ho NJ, Gelbart T. Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease. Acta Haematol 2002;107:145-9.
111. Mei Z, Cogswell ME, Parvanta I, Lynch S, Beard JL, Stoltzfus RJ, et al. Hemoglobin and ferritin are currently the most efficient indicators of population response to iron interventions: an analysis of nine randomized controlled trials. J Nutr 2005;135:1974-80.
112. Hulten L, Gramatkovski E, Gleerup A, Hallberg L. Iron absorption from the whole diet. Relation to meal composition, iron requirements and iron stores. Eur J Clin Nutr 1995;49:794-808.
113. Hallberg L, Hulten L, Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption? Am J Clin Nutr 1997;66:347-56.
114. Gleerup A, Rossander-Hulthen L, Gramatkovski E, Hallberg L. Iron absorption from the whole diet: comparison of the effect of two different distributions of daily calcium intake. Am J Clin Nutr 1995; 61:97-104.
115. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306: 2090-3.
116. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc Natl Acad Sci U S A 2001;98:8160-2.
117. Ganz T. Hepcidin and iron regulation, 10 years later. Blood 2011; 117:4425-33.
118. Mannello F, Tonti GA, Simone P, Ligi D, Medda V. Iron-binding proteins and C-reactive protein in Nipple Aspirate Fluids: role of Iron-driven inflammation in breast cancer microenvironment? Am J Transl Res 2010;3:100-13.
119. Wannamethee SG, Shaper AG. Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 1999;22:1266-72.
120. Hallberg L, Brune M, Rossander L. Effect of ascorbic acid on iron absorption from different types of meals. Studies with ascorbic-acidrich foods and synthetic ascorbic acid given in different amounts with different meals. Hum Nutr Appl Nutr 1986;40:97-113.
121. Villegas R, Shu XO, Yang G, Matthews CE, Li H, Cai H, et al. Energy balance and type 2 diabetes: a report from the Shanghai Women's Health Study. Nutr Metab Cardiovasc Dis 2009;19:190-7.
122. Colditz GA, Manson JE, Stampfer MJ, Rosner B, Willett WC, Speizer FE. Diet and risk of clinical diabetes in women. Am J Clin Nutr 1992;55:1018-23.